AVROBIO, Inc.
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modif…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
AVROBIO, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
AVROBIO, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of AVROBIO, Inc..